Navigation Links
Hope For Patients With Advanced Breast Cancer

A recent study identified a specific gene that’s responsible for controlling the activated leukocyte cell adhesion molecule ( ALCAM ), which plays a role in helping // cells stay clumped together. The gene is less active in aggressive tumors than in normal breast tissue or tumors that don’t result in a spreading of the disease. Researchers speculate less activity on the part of ALCAM allows tumor cells to more easily separate and migrate to other areas of the body, causing cancer to spread.

Researchers believe they have found an “early warning system” for aggressive breast cancers that will allow them to treat more serious tumors with stronger medicines earlier on in the disease process.The gene can be identified using a test that measures its level of activity in tissue. If the gene is found to be less active in tumor tissue, then the woman can undergo chemotherapy earlier in the course of her disease and possibly avoid progression.

Researchers conducted the study by comparing ALCAM activity in frozen samples of 120 tumors and in 32 samples of normal breast tissue. Women who had died of breast cancer had tumors with notably lower levels of ALCAM than those who did not. Lower levels were also seen in tumors from patients whose cancer spread or recurred.

Researchers say their data clearly suggest that decreased ALCAM expression in the primary tumor is of clinical significance in breast cancer and that reduced expression indicates a more aggressive phenotype and poor prognosis.
'"/>




Page: 1

Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Amphetamines Help Recovery of Stroke Patients
3. Painkillers Do Not Shorten Dying Patients Lives
4. Patients With Filariasis More Prone To HIV Infection
5. Glivec - New Hope For CMC Patients
6. Patients often assume wrongly that they are allergic to penicillin
7. New FDA Approved Drug NATRECOR For Heart Failure Patients
8. Hemochromatosis Patients Blood is Safe
9. Patients Pressure Would Result In Overprescription
10. Risk Of Decongestants In Hypertensive Patients
11. Interference helps Heart Patients
Post Your Comments:
(Date:7/18/2008)...Cain Is Not What America Signed Up For, WASHINGTO...ohn McCain,s,top economic advisor, Phil Gramm, ech...lems were "psychological" by saying Americans are ...e a "nation of whiners." While McCain,distanced hi... board as,McCain,s top economic adviser. Now, John...
(Date:7/18/2008)...ildren preventive antibiotics within one hour befo... risk for serious infections after the surgery, su...e August issue of Pediatric Infectious Disease Jo...ldren who received antibiotics outside of the gold...likely to develop serious infections at the surger...
(Date:7/18/2008)...ld help advance individualized medicine for psychi...thDay News) -- Scientists may have found more evid...rmine whether or not they respond to the antidepre...archers at the Mayo Clinic have found that variati...elect which patients should try this drug, one of ...
(Date:7/18/2008)...Home Journal Cites Work with Women Veterans, WASH...la Schnurr,deputy executive director for VA,s Nat...TSD), received the 3rd annual Ladies Home Journal ... and women veterans., "Dr. Schnurr,s contribution...rtment,s commitment to healing those who have born...
Breaking Medicine News(10 mins):Health News:DNC: McCain Watch: The Economy 2Health News:DNC: McCain Watch: The Economy 3Health News:Averting postsurgical infections in kids: Give antibiotics within hour before first incision 2Health News:Gene Variations May Predict Antidepressant Response 2
... study to be published in the September 2006 issue...isk of miscarriage in pregnant women seeking prena...mosomal abnormalities is lower than previously bel...is and chorionic villus sampling (CVS)--are common...
...ing of his lungs weakens. According to researchers.../ An 8-year study was conducted on 670 men, 45 – ... levels of long-standing anger at the beginning of... lung function at the end of it. "This study is o...
... out to be the worst enemy for asthmatic children....’s response to air pollution says a recent study./...tion between chronic cough, phlegm production (bro... Dr. Rob McConnell, professor of preventive medici...
...lity of growth of colon polyps to half, it doubles...evealed by two significant studies published in th...cine. The opinions of Bruce M. Psaty, M.D., Ph.D.,...f the University of Washington were also published...
Other Medicine News:Health News:Prenatal Test and Miscarriage 2Health News:Prenatal Test and Miscarriage 3Health News:Dogs aggravate asthma in kids 2Health News:Celebrex- pros and cons 2
(Date:7/17/2008).../ -- The Michael J. Fox,Foundation for Parkinson,s...on in total funding to nine research teams under i...program provides intellectual and financial,resour... toward clinical,trials and ultimately the nearly ...e discovery of a new potential therapeutic target ...
(Date:7/17/2008)...orate Milestone and Advances ...7 /- Meditrina Pharmaceuticals,Inc. ...gational new drug,(IND) application for a Phase II...e Company,s aromatase inhibitor (AI), in combinati...f endometriosis. MPI-676 is the,newest addition to...
(Date:7/17/2008)... observed in advanced non-small, cell lung cancer ...andard chemotherapy ...r patients with adenocarcinoma, the most .../- BioNumerik Pharmaceuticals, Inc.,(...denocarcinoma (the most,frequently occurring form ...
(Date:7/16/2008).../ -- Vical Incorporated,(Nasdaq: VICL ) today ann...ial data demonstrating that DNA vaccines can safel...1 pandemic influenza in humans. DNA vaccines,are f...because they do not,contain any part of the virus ...ponse to a pandemic outbreak because of significan...
Breaking Medicine Technology:Michael J. Fox Foundation Awards $2.4 Million for Validation of Nine Promising Therapeutic Targets for Parkinson's Disease 2Michael J. Fox Foundation Awards $2.4 Million for Validation of Nine Promising Therapeutic Targets for Parkinson's Disease 3Meditrina Pharmaceuticals, Inc. Opens Investigational New Drug (IND) Application for Phase IIb Clinical Trial With MPI-676 in Endometriosis 2Meditrina Pharmaceuticals, Inc. Opens Investigational New Drug (IND) Application for Phase IIb Clinical Trial With MPI-676 in Endometriosis 3Meditrina Pharmaceuticals, Inc. Opens Investigational New Drug (IND) Application for Phase IIb Clinical Trial With MPI-676 in Endometriosis 4BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial 2BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial 3BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial 4Vical Announces Breakthrough for Pandemic Influenza DNA Vaccines With Preliminary Human Data 2Vical Announces Breakthrough for Pandemic Influenza DNA Vaccines With Preliminary Human Data 3Vical Announces Breakthrough for Pandemic Influenza DNA Vaccines With Preliminary Human Data 4Vical Announces Breakthrough for Pandemic Influenza DNA Vaccines With Preliminary Human Data 5Vical Announces Breakthrough for Pandemic Influenza DNA Vaccines With Preliminary Human Data 6Wells Fargo Health Savings Accounts Grow to Quarter Billion Dollars 19777 1Wells Fargo Health Savings Accounts Grow to Quarter Billion Dollars 19777 2Prof Dr George Gettinby Honored With Dieter Lutticken Award 19775 1Prof Dr George Gettinby Honored With Dieter Lutticken Award 19775 2Prof Dr George Gettinby Honored With Dieter Lutticken Award 19775 3MagSense to Exhibit Its Scientific and Clinical Applications at International Magnetic Carriers Conference 5513 1MagSense to Exhibit Its Scientific and Clinical Applications at International Magnetic Carriers Conference 5513 2Childrens gardens mushrooming 3360 1Childrens gardens mushrooming 3360 2
...Results at 2007 American Association for,Cancer Re...PRNewswire-FirstCall/ -- Cleveland,BioLabs, Inc. ,...ctan CBLB502,s efficacy as a mitigator of both,gas...blood,production) radiation-induced damage in non-...icer, Andrei Gudkov, Ph.D, D. Sci.,will present r...
... 2007 /PRNewswire-FirstCall/ -- Kosan,Biosciences ...he,Company,s clinical and preclinical pipeline, in...r export inhibitor programs, at the,2007 Annual Me...rch,(AACR), being held in Los Angeles, April 14-18... are as follows. The,location for all poster prese...
Other Medicine Technology:Cleveland BioLabs Protectan CBLB502 Demonstrates Strong Survival,Benefits as Mitigator Against Radiation-Induced Damage in Study 2Cleveland BioLabs Protectan CBLB502 Demonstrates Strong Survival,Benefits as Mitigator Against Radiation-Induced Damage in Study 3Kosan Announces Data Presentations at Upcoming AACR Annual Meeting 2Kosan Announces Data Presentations at Upcoming AACR Annual Meeting 3
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 9.0 mm and length 9 mm.
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 9.0 mm and length 10 mm.
The BacT/Alert 3D Signature is a state of the art, automated microbial detection system that integrates blood, sterile body fluid and mycobacteria culturing. It is a powerful microbiology workstation
The Vitek 2 - XL is a fully automated bacteriology system that performs bacterial identification and susceptibility testing analysis using a standard inoculum. It detects resistance and helps combat
Medicine Products: